Factors predicting for urinary incontinence after prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 5, 2004, Pages 1395-1404

  McElveen, Tracy L ^a   Waterman, Frank M ^a   Kim, Hayeon ^a   Dicker, Adam P ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Brachytherapy; Prostate; Quality of life; Urinary incontinence

Indexed keywords

BRACHYTHERAPY; URINARY INCONTINENCE;

COMPUTERIZED TOMOGRAPHY; DISEASE CONTROL; DOSIMETRY; HEALTH RISKS; ONCOLOGY; TOXICITY; TUMORS;

RADIOTHERAPY;

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; COUGHING; DOSIMETRY; EVALUATION; EXPERIENCE; FOLLOW UP; HISTOGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE; NONVERBAL COMMUNICATION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; RATING SCALE; RISK FACTOR; SCORING SYSTEM; SELF EVALUATION; SNEEZING; SYMPTOM; URINE INCONTINENCE;

AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION DOSAGE; RISK FACTORS; URETHRA; URINARY INCONTINENCE;

EID: 3242728788     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.01.050     Document Type: Article

References (42)

1. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:1998;969-974
2. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol. 17:1999;517-522
3. Ragde H., Blasko J.C., Grimm P.D., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 80:1997;442-453
4. Ragde H., Blasko J.C., Grimm P.D., et al. Brachytherapy for clinically localized prostate cancer Results at 7- and 8-year follow-up. Semin Surg Oncol. 13:1997;438-443
5. Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma [Review]. Cancer 1998;83:989-1001
6. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 14:1996;449-453
7. Eastham J.A., Kattan M.W., Groshen S., et al. Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. J Clin Oncol. 15:1997;3214-3222
8. Gerber G.S., Thisted R.A., Chodak G.W., et al. Results of radical prostatectomy in men with locally advanced prostate cancer Multi-institutional pooled analysis. Eur Urol. 32:1997;385-390
9. Zincke H., Bergstralh E.J., Blute M.L., et al. Radical prostatectomy for clinically localized prostate cancer Long-term results of 1,143 patients from a single institution. J Clin Oncol. 12:1994;2254-2263
10. Fowler F.J. Jr., Barry M.J., Lu-Yao G., et al. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience 1988-1990 (updated June 1993). Urology. 42:1993;622-629
11. Talcott J.A., Clark J.A., Stark P.C., et al. Long-term treatment related complications of brachytherapy for early prostate cancer A survey of patients previously treated. J Urol. 166:2001;494-499
12. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 45:1999;59-67
13. Kaye K.W., Olson D.J., Payne J.T. Detailed preliminary analysis of 125iodine implantation for localized prostate cancer using percutaneous approach. J Urol. 153:1995;1020-1025
14. Brown D., Colonias A., Miller R., et al. Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation. Int J Radiat Oncol Biol Phys. 47:2000;353-360
15. Stokes S.H., Real J.D., Adams P.W., et al. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 37:1997;337-341
16. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Investig. 6:1998;135-141
17. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135
18. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer Results of the CaPSURE database. J Urol. 159:1998;1988-1992
19. Slevin M.L., Plant H., Lynch D., et al. Who should measure quality of life, the doctor or the patient? Br J Cancer. 57:1988;109-112
20. Litwin M.S., Hays R.D., Fink A., et al. The UCLA Prostate Cancer Index Development, reliability, and validity of a health-related quality of life measure. Med Care. 36:1998;1002-1012
21. Nag S., Ellis R.J., Merrick G.S., et al. American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 54:2002;462-470
22. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria Version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;13-47
23. Trotti A. The evolution and application of toxicity criteria. Semin Radiat Oncol. 12:2002;1-3
24. Roy J.N., Wallner K.E., Harrington P.J., et al. A CT-based evaluation method for permanent implants Application to prostate. Int J Radiat Oncol Biol Phys. 26:1993;163-169
25. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46:2000;221-230
26. Waterman F.M., Dicker A.P. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan. Med Phys. 27:2000;448-451
27. Lee H.K., D'Souza W.D., Yamal J.M., et al. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 57:2003;355-361
28. Waterman F.M., Dicker A.P. The impact of postimplant edema on the urethral dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;661-664
29. Merrick G.S., Butler W.M., Wallner K.E., et al. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 56:2003;454-461
30. Wei J.T., Dunn R.L., Litwin M.S., et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 56:2000;899-905
31. Wallner K., Roy J., Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 32:1995;465-471
32. Merrick G.S., Butler W.M., Tollenaar B.G., et al. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys. 52:2002;461-468
33. Zelefsky M.J., Yamada Y., Marion C., et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 55:2003;956-963
34. Terk M.D., Stock R.G., Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 160:1998;1379-1382
35. Barry M.J., Fowler F.J. Jr., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 148:(5):1992;1549-1557
36. Merrick G.S., Butler W.M., Wallner K.E., et al. Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology. 60:2002;650-655
37. Merrick G.S., Butler W.M., Lief J.H., et al. Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;121-128
38. Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy A prospective study. Int J Radiat Oncol Biol Phys. 52:2002;712-719
39. Bucci J., Morris W.J., Keyes M., et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 53:2002;91-98
40. Hu K., Wallner K. Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;783-786
41. Litwin M.S. Health related quality of life in older men without prostate cancer. J Urol. 161:1999;1180-1184
42. Thom D. Variation in estimates of urinary incontinence prevalence in the community Effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc. 46:1998;473-480